Race Executive Director on Disrupt Radio

Race Oncology Executive Director Dr Peter Smith joined Disrupt Radio to discuss building biotech businesses in Australia, what to look out for when investing in biotech businesses, and why Race’s lead drug bisantrene is a unique asset carrying great clinical and commercial potential.

You can listen to Dr Smith’s full interview via this link.